Macular Degeneration Treatment Market Ready to Reach US$ 13,195.7 MN By 2028 with CAGR 7.0% during the Forecast Period 2022-2028

 

Macular Degeneration Treatment Market

Macular Degeneration is an eye disease that causes loss of central vision by affecting the macula (the centre of the light-sensitive retina at the back of the eye). Age-related macular degeneration (AMD) is a vision disorder that causes central vision to blur. It occurs when ageing causes damage to the macula, a component of the retina (the light-sensitive tissue at the back of the eye). There are two kinds of age-related macular degeneration: dry and wet.

The majority of AMD patients have dry AMD. This is the process by which the macula thins with age. Dry macular degeneration is a common eye condition in people over the age of 50. Wet AMD is characterised by rapid and progressive central vision loss as a result of leaking blood vessels in the eyes. Although there is no cure, treatment for macular degeneration (AMD) may slow the disease and prevent severe vision loss. Consult a doctor to determine the best course of action.

During the forecast period, the global geriatric population is expected to drive the growth of the global macular degeneration treatment market. Retinal disorders became more common as people aged. AMD is the most common cause of blindness in developed countries, especially among people over the age of 60. According to the World Health Organization (WHO), there were one billion people aged 60 and up in 2019. This figure is expected to rise to approximately 1.4 billion by 2030 and 2.1 billion by 2050.

The Global Macular Degeneration Treatment Market Was Valued At US$ 8,208.7 Mn In 2021 And Is Forecast To Reach A Value Of US$ 13,195.7 Mn By 2028 At A CAGR Of 7.0% Between 2022 And 2028.

The Global Macular Degeneration Treatment Market is expected to be hampered by a lack of awareness about the disease. AMD is a leading cause of irreversible blindness, and raising awareness about the disease is critical to preventing blindness. However, there is a significant lack of awareness about AMD among the general public, particularly in developing countries. To raise awareness about AMD, large-scale public campaigns and educational programmes are required.

The growing use of off-label medications is expected to stymie the growth of the Macular Degeneration Treatment Market. Off-label drug use is the practise of prescribing a drug for a purpose other than what the FDA has approved. The MHRA (Medicines and Healthcare products Regulatory Agency) clarified its position on the use of Roche's Avastin off-label as a treatment for wet AMD in September 2019. The High Court ruled in 2018 that CCGs can prescribe Bevacizumab (Avastin) for wet AMD off-label.

Global Macular Degeneration Treatment Market Segmentations-

·        By Type: Dry Age-related Macular Degeneration and Wet Age-related Macular Degeneration

·        By Stage Of Disease: Early-stage AMD, Intermediate AMD, and Late-stage AMD

·        By Route Of Administration: Intravenous Route and Intravitreal Route

·        By Sales Channel: Ambulatory Surgical Centres, Hospitals, and Other Sales Channels

Topmost Manufacturers are- Bayer AG, REGENXBIO Inc., Aerie Pharmaceutical Inc., Panoptica, Pfizer Inc., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceutical Inc., Novartis AG, and Bausch Health Companies Inc., among others

Read the Press Release of Macular Degeneration Treatment Market 

Comments

Post a Comment

Popular posts from this blog

Forging has significant application in creation of various metal for wide range of applications

Image
Forging refers to any process that produces metal from scratch by subjecting it to an external force. Metal forgers can be persons or machines. This techniques may involve grinding (for example, to produce alloyed steel) or may involve the application of pressure to apply heat to the metal piece until it is malleable. The actual process depends on various factors, including the material being forged, its shape, and the degree of stress that is placed on it. Forged grain is the product of Forging with grains of metals pushed against each other through a forge-like tool and into the cladding that forms the final shape of the metal after it has been done. It is the principal production process in most metals. It uses local or repetitive thrusts delivered by a hammer or die to apply mechanical blows to the metal piece until it becomes malleable. It is frequently classified according to the speed at which it's done: fast, cold, or hot. There are many types of forgers available today...
Read more

Ginseng Market Outlook, Analysis and forecast up to 2028

Image
  Ginseng Market Ginseng is a slow-growing perennial plant with green oval-shaped leaves and meaty roots that can persist for more than a century. Ginseng is classified into two types: American ginseng and Asian ginseng. Panax quinquefolius is the scientific name for American ginseng, whereas Panax ginseng is the scientific name for Asian ginseng. Ginseng is widely used as a herb to increase the body's energy levels. Ginseng's antioxidant and anti-inflammatory qualities serve to enhance the immune system, lowering the risk of viral and microbial infections. Ginseng also helps to lower the risk of diseases such as lung cancer, skin cancer, and liver cancer. Other health advantages of ginseng include lower blood sugar levels and improved cognitive functions such as memory and conduct. Ginseng is mostly grown in the United States, Canada, and South Korea. Ginseng has been used as a herbal medicine in China for generations, and the country is one of its largest users. Asia Pacifi...
Read more

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19

Image
Germany Vaccine Contract Manufacturing industry is expected to witness significant growth in the near future, due to emergence of Covid-19. In Germany, from 3 January 2020 to 4:06pm CEST, 18 August 2021, there have been 3,835,375 confirmed cases of COVID-19 with 91,921 deaths, reported to WHO. As of 15 August 2021, a total of 97,884,043 vaccine doses have been administered. The increasing demand for safe and cost-effective vaccines due to unmatchable quality, consistent delivery, and unparalleled security, have contributed to the increasing growth and scope of this industry. The increasing demand for vaccines and resulting profit potential have led to significant growth in the number of contract manufacturing plants located across the world. A major focus of such plants is developing cost effective, high quality vaccines that could be made available to public health organizations and other medical organizations. Several new and innovative technologies are also being developed to man...
Read more